BDNF repairs podocyte damage by microRNA-mediated increase of actin polymerization

Journal of Pathology

Volumn 235, Issue 5, 2015, Pages 731-744

  Li, Min ^a   Armelloni, Silvia ^a   Zennaro, Cristina ^b   Wei, Changli ^c   Corbelli, Alessandro ^a,d   Ikehata, Masami ^a   Berra, Silvia ^a,e   Giardino, Laura ^a   Mattinzoli, Deborah ^a   Watanabe, Shojiro ^a   Agostoni, Carlo ^e   Edefonti, Alberto ^a   Reiser, Jochen ^c   Messa, Piergiorgio ^a   Rastaldi, Maria Pia ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

actin cytoskeleton; adriamycin nephropathy; brain derived neurotrophic factor; podocyte

Indexed keywords

ACTIN; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; COFILIN; LIM KINASE 1; MICRORNA; MICRORNA 132; MICRORNA 134; UNCLASSIFIED DRUG; ACTIN DEPOLYMERIZING FACTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; LIM KINASE; MIRN132 MICRORNA, HUMAN; MIRN132 MICRORNA, MOUSE; MIRN134 MICRORNA, HUMAN; MIRN134 MICRORNA, MOUSE; RECOMBINANT PROTEIN;

ACTIN POLYMERIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; UPREGULATION; ZEBRA FISH; 3T3 CELL LINE; ACTIN FILAMENT; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; LARVA; METABOLISM; PATHOLOGY; PHOSPHORYLATION; POLYMERIZATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTOR;

3T3 CELLS; ACTIN CYTOSKELETON; ACTIN DEPOLYMERIZING FACTORS; ACTINS; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; LARVA; LIM KINASES; MALE; MICE; MICE, INBRED BALB C; MICRORNAS; PHOSPHORYLATION; PODOCYTES; POLYMERIZATION; PROTEINURIA; RECEPTOR, TRKB; RECOMBINANT PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; ZEBRAFISH;

EID: 84924596430     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4484     Document Type: Article

References (61)

1. Gbadegesin R, Lavin P, Foreman J, et al., Pathogenesis and therapy of focal segmental glomerulosclerosis: an update. Pediatr Nephrol 2011; 26: 1001-1015.
2. Braun N, Schmutzler F, Lange C, et al., Immunosuppressive treatment for focal segmental glomerulosclerosis in adults. Cochrane Database Syst Rev 2008; (3): CD003233.
3. Reiser J, Sever S,. Podocyte biology and pathogenesis of kidney disease. Annu Rev Med 2013; 64: 357-366.
4. Giardino L, Armelloni S, Corbelli A, et al., Podocyte glutamatergic signaling contributes to the function of the glomerular filtration barrier. J Am Soc Nephrol 2009; 20: 1929-1940.
5. Puliti A, Rossi PI, Caridi G, et al., Albuminuria and glomerular damage in mice lacking the metabotropic glutamate receptor 1. Am J Pathol 2011; 178: 1257-1269.
6. Brunskill EW, Georgas K, Rumballe B, et al., Defining the molecular character of the developing and adult kidney podocyte. PLoS One 2011; 6: e24640.
7. Boerries M, Grahammer F, Eiselein S, et al., Molecular fingerprinting of the podocyte reveals novel gene and protein regulatory networks. Kidney Int 2013; 83: 1052-1064.
8. Vitureira N, Andrés R, Pérez-Martínez E, et al., Podocalyxin is a novel polysialylated neural adhesion protein with multiple roles in neural development and synapse formation. PLoS One 2010; 5: e12003.
9. Li M, Armelloni S, Ikehata M, et al., Nephrin expression in adult rodent central nervous system and its interaction with glutamate receptors. J Pathol 2011; 225: 118-128.
10. Armelloni S, Li M, Messa P, et al., Podocytes: a new player for glutamate signaling. Int J Biochem Cell Biol 2012; 44: 2272-2277.
11. Faul C, Asanuma K, Yanagida-Asanuma E, et al., Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol 2007; 17: 428-437.
12. Cingolani LA, Goda Y,. Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy. Nature Rev Neurosci 2008; 9: 344-356.
13. Sala C, Segal M,. Dendritic spines: the locus of structural and functional plasticity. Physiol Rev 2014; 94: 141-188.
14. Greka A, Mundel P,. Cell biology and pathology of podocytes. Annu Rev Physiol 2012; 74: 299-323.
15. Morse JK, Wiegand SJ, Anderson K, et al., Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection. J Neurosci 1993; 13: 4146-4156.
16. Yurek DM, Lu W, Hipkens S, et al., BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons. Exp Neurol 1996; 137: 105-118.
17. Han BH, Holtzman DM,. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci 2000; 20: 5775-5781.
18. Arancibia S, Silhol M, Moulière F, et al., Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats. Neurobiol Dis 2008; 31: 316-326.
19. Nagahara AH, Merrill DA, Coppola G, et al., Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nature Med 2009; 15: 331-337.
20. Stahl K, Mylonakou MN, Skare Ø, et al., Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease. Brain Res 2011; 1378: 105-118.
21. Yamamoto M, Sobue G, Yamamoto K, et al., Expression of mRNAs for neurotrophic factors (NGF, BDNF, NT-3, and GDNF) and their receptors (p75NGFR, trkA, trkB, and trkC) in the adult human peripheral nervous system and nonneural tissues. Neurochem Res 1996; 21: 929-938.
22. García-Suárez O, González-Martínez T, Germana A, et al., Expression of TrkB in the murine kidney. Microsc Res Tech 2006; 69: 1014-1020.
23. De Girolamo P, Arcamone N, Lucini C, et al., TRK neurotrophin receptor-like proteins in the kidney of frog (Rana esculenta) and lizard (Podarcis sicula): an immunohistochemical study. Anat Embryol (Berl) 2004; 207: 481-487.
24. De Girolamo P, Arcamone N, Lucini C, et al., The teleost kidney expresses Trk neurotrophin receptor-like proteins. Anat Embryol (Berl) 2000; 201: 429-433.
25. Shibayama E, Koizumi H,. Cellular localization of the Trk neurotrophin receptor family in human non-neuronal tissues. Am J Pathol 1996; 148: 1807-1818.
26. Durbeej M, Söderström S, Ebendal T, et al., Differential expression of neurotrophin receptors during renal development. Development 1993; 119: 977-989.
27. Jin X, Hu H, Mathers PH, et al., Brain-derived neurotrophic factor mediates activity-dependent dendritic growth in nonpyramidal neocortical interneurons in developing organotypic cultures. J Neurosci 2003; 23: 5662-5673.
28. Westerfield, M., The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (Danio rerio) (4th edn). University of Oregon Press: Eugene, 2000.
29. Zennaro C, Mariotti M, Carraro M, et al., Podocyte developmental defects caused by adriamycin in zebrafish embryos and larvae: a novel model of glomerular damage. PLoS One 2014; 9: e98131.
30. Hentschel DM, Mengel M, Boehme L, et al., Rapid screening of glomerular slit diaphragm integrity in larval zebrafish. Am J Physiol Renal Physiol 2007; 293: F1746-F1750.
31. Yan Q, Matheson C, Lopez OT, et al., The biological responses of axotomized adult motoneurons to brain-derived neurotrophic factor. J Neurosci 1994; 14: 5281-5291.
32. Schäbitz WR, Steigleder T, Cooper-Kuhn CM, et al., Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke 2007; 38: 2165-2172.
33. Ninkina N, Adu J, Fischer A, et al., Expression and function of TrkB variants in developing sensory neurons. EMBO J 1996; 15: 6385-6393.
34. Cazorla M, Arrang JM, Prémont J,. Pharmacological characterization of six trkB antibodies reveals a novel class of functional agents for the study of the BDNF receptor. Br J Pharmacol 2011; 162: 947-960.
35. Bonofiglio R, Antonucci MT, Papalia T, et al., Nerve growth factor (NGF) and NGF-receptor expression in diseased human kidneys. J Nephrol 2007; 20: 186-195.
36. Scott RW, Olson MF,. LIM kinases: function, regulation and association with human disease. J Mol Med (Berl) 2007; 85: 555-568.
37. Schratt GM, Tuebing F, Nigh EA, et al., A brain-specific microRNA regulates dendritic spine development. Nature 2006; 439: 283-289.
38. Wayman GA, Davare M, Ando H, et al., An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc Natl Acad Sci U S A 2008; 105: 9093-9098.
39. Numakawa T, Richards M, Adachi N, et al., MicroRNA function and neurotrophin BDNF. Neurochem Int 2011; 59: 551-558.
40. Marler KJ, Suetterlin P, Dopplapudi A, et al., BDNF promotes axon branching of retinal ganglion cells via miRNA-132 and p250GAP. J Neurosci 2014; 34: 969-979.
41. Lu B, Nagappan G, Guan X, et al., BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nature Rev Neurosci 2013; 14: 401-416.
42. Kim H, Li Q, Hempstead BL, et al., Paracrine and autocrine functions of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in brain-derived endothelial cells. J Biol Chem 2004; 279: 33538-33546.
43. Kajiya M, Shiba H, Fujita T, et al., Brain-derived neurotrophic factor protects cementoblasts from serum starvation-induced cell death. J Cell Physiol 2009; 221: 696-706.
44. Fenner BM,. Truncated TrkB: beyond a dominant negative receptor. Cytokine Growth Factor Rev 2012; 23: 15-24.
45. Tyler WJ, Pozzo-Miller LD,. BDNF enhances quantal neurotransmitter release and increases the number of docked vesicles at the active zones of hippocampal excitatory synapses. J Neurosci 2001; 21: 4249-4258.
46. Tyler WJ, Pozzo-Miller L,. Miniature synaptic transmission and BDNF modulate dendritic spine growth and form in rat CA1 neurones. J Physiol 2003; 553: 497-509.
47. Ji Y, Pang PT, Feng L, et al., Cyclic AMP controls BDNF-induced TrkB phosphorylation and dendritic spine formation in mature hippocampal neurons. Nature Neurosci 2005; 8: 164-172.
48. Hotulainen P, Hoogenraad CC,. Actin in dendritic spines: connecting dynamics to function. J Cell Biol 2010; 189: 619-629.
49. Segal M, Vlachos A, Korkotian E,. The spine apparatus, synaptopodin, and dendritic spine plasticity. Neuroscientist 2010; 16: 125-131.
50. Theriot JA,. Regulation of the actin cytoskeleton in living cells. Semin Cell Biol 1994; 5: 193-199.
51. Mizuno K., Signaling mechanisms and functional roles of cofilin phosphorylation and dephosphorylation. Cell Signal 2013; 25: 457-469.
52. Garg P, Verma R, Cook L, et al., Actin-depolymerizing factor cofilin-1 is necessary in maintaining mature podocyte architecture. J Biol Chem 2010; 285: 22676-22688.
53. Meng Y, Zhang Y, Tregoubov V, et al., Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice. Neuron 2002; 35: 121-133.
54. Gray V, Karmiloff-Smith A, Funnell E, et al., In-depth analysis of spatial cognition in Williams syndrome: a critical assessment of the role of the LIMK1 gene. Neuropsychologia 2006; 44: 679-685.
55. Akagawa H, Tajima A, Sakamoto Y, et al., A haplotype spanning two genes, ELN and LIMK1, decreases their transcripts and confers susceptibility to intracranial aneurysms. Hum Mol Genet 2006; 15: 1722-1734.
56. The BDNF Study Group. A controlled trial of recombinant methionyl human BDNF in ALS: the BDNF Study Group (phase III). Neurology 1999; 52: 1427-1433.
57. Thiele CJ, Li Z, McKee AE,. On Trk-the TrkB signal transduction pathway is an increasingly important target in cancer biology. Clin Cancer Res 2009; 15: 5962-5967.
58. Mundel P, Reiser J, Zúñiga Mejía Borja A, et al. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 1997; 236: 248-258.
59. Mikami Y, Suzuki S, Ishii Y, et al. The p75 neurotrophin receptor regulates MC3T3-E1 osteoblastic differentiation. Differentiation 2012; 84: 392-399.
60. Mattinzoli D, Messa P, Corbelli A, et al., A novel model of in vitro osteocytogenesis induced by retinoic acid treatment. Eur Cell Mater 2012; 24: 403-425.
61. Rønn LC, Ralets I, Hartz BP, et al. A simple procedure for quantification of neurite outgrowth based on stereological principles. J Neurosci Methods 2000; 100: 25-32.